Kickstarting the use of AI for biotechs: part one
Drug Target Review
MAY 15, 2024
Of course, with the billions of dollars being invested in AI-led drug discovery programmes, one would think that this is a pivotal moment in patient treatment – like Isomorphic Labs, Recursion, Exscientia, Flagship Pioneering, the big biopharmaceuticals, and even a “$1B+ bet” 2 on Xaira Therapeutics, who have invested heavily in the promise of AI.
Let's personalize your content